Impact of the Antithrombotic Effects of Prasugrel on Mid-Term Vascular Healing in Acute Coronary Syndrome vs. Stable Coronary Artery Disease.
CONCLUSIONS: In patients undergoing EES implantation and receiving prasugrel, achieving an adequate antiplatelet effect at the time of stent implantation may regulate thrombus formation throughout the follow-up period.
PMID: 33431718 [PubMed - as supplied by publisher]
Source: Circulation Journal - Category: Cardiology Authors: Toba T, Shinke T, Otake H, Kawamori H, Matsukawa N, Matsuura A, Ishihara T, Matsumoto D, Igarashi N, Hayashi T, Yasaka Y, Kadotani M, Fujii T, Shite J, Okada M, Sakakibara T, Hirata KI Tags: Circ J Source Type: research
More News: Angioplasty | Aspirin | Cardiology | Coronary Angioplasty | Percutaneous Coronary Intervention | Study | Thrombosis